343 related articles for article (PubMed ID: 11496937)
21. Interrelation of permeation and penetration parameters obtained from in vitro experiments with human skin and skin equivalents.
Wagner H; Kostka KH; Lehr CM; Schaefer UF
J Control Release; 2001 Aug; 75(3):283-95. PubMed ID: 11489316
[TBL] [Abstract][Full Text] [Related]
22. Assessment of the percutaneous penetration of cisplatin: the effect of monoolein and the drug skin penetration pathway.
Simonetti LD; Gelfuso GM; Barbosa JC; Lopez RF
Eur J Pharm Biopharm; 2009 Sep; 73(1):90-4. PubMed ID: 19442727
[TBL] [Abstract][Full Text] [Related]
23. Enhanced skin permeation of a lipophilic drug using supersaturated formulations.
Moser K; Kriwet K; Kalia YN; Guy RH
J Control Release; 2001 Jun; 73(2-3):245-53. PubMed ID: 11516502
[TBL] [Abstract][Full Text] [Related]
24. In vitro permeation of carvedilol through porcine skin: effect of vehicles and penetration enhancers.
Gannu R; Vishnu YV; Kishan V; Rao YM
PDA J Pharm Sci Technol; 2008; 62(4):256-63. PubMed ID: 19174954
[TBL] [Abstract][Full Text] [Related]
25. Structure-permeability relationship analysis of the permeation barrier properties of the stratum corneum and viable epidermis/dermis of rat skin.
Yamaguchi K; Mitsui T; Aso Y; Sugibayashi K
J Pharm Sci; 2008 Oct; 97(10):4391-403. PubMed ID: 18228598
[TBL] [Abstract][Full Text] [Related]
26. Drug and vehicle deposition from topical applications: use of in vitro mass balance technique with minoxidil solutions.
Tsai JC; Cappel MJ; Flynn GL; Weiner ND; Kreuter J; Ferry JJ
J Pharm Sci; 1992 Aug; 81(8):736-43. PubMed ID: 1403715
[TBL] [Abstract][Full Text] [Related]
27. A thermodynamic and kinetic analysis of human epidermal penetration of phenolic compounds: II. Maximum flux and solute diffusion through stratum corneum lipids.
Zhang Q; Alinaghi A; Williams DB; Roberts MS
Int J Pharm; 2023 Jan; 631():122522. PubMed ID: 36563793
[TBL] [Abstract][Full Text] [Related]
28. Characterization of Water and a Model Lipophilic Compound in Human Stratum Corneum by NMR Spectroscopy and Equilibrium Sorption.
Kodiweera C; Romonchuk WJ; Yang Y; Bunge AL
J Pharm Sci; 2016 Nov; 105(11):3376-3386. PubMed ID: 27671234
[TBL] [Abstract][Full Text] [Related]
29. Characterization of a liposome-based artificial skin membrane for in vitro permeation studies using Franz diffusion cell device.
Zhang H; Zhu X; Shen J; Xu H; Ma M; Gu W; Jiang Q; Chen J; Duan J
J Liposome Res; 2017 Dec; 27(4):302-311. PubMed ID: 27581379
[TBL] [Abstract][Full Text] [Related]
30. Enhancement of Skin Permeation of a Hydrophilic Drug from Acryl-Based Pressure-Sensitive Adhesive Tape.
Suzuki T; Aoki T; Saito M; Hijikuro I; Itakura S; Todo H; Sugibayashi K
Pharm Res; 2021 Feb; 38(2):289-299. PubMed ID: 33515137
[TBL] [Abstract][Full Text] [Related]
31. Analysis of skin penetration enhancement based on a two-layer skin diffusion model with polar and nonpolar routes in the stratum corneum: dose-dependent effect of 1-geranylazacycloheptan-2-one on drugs with different lipophilicities.
Yamashita F; Yoshioka T; Koyama Y; Okamoto H; Sezaki H; Hashida M
Biol Pharm Bull; 1993 Jul; 16(7):690-7. PubMed ID: 8401404
[TBL] [Abstract][Full Text] [Related]
32. In vitro-in vivo correlation in skin permeation.
Mohammed D; Matts PJ; Hadgraft J; Lane ME
Pharm Res; 2014 Feb; 31(2):394-400. PubMed ID: 23943545
[TBL] [Abstract][Full Text] [Related]
33. In vitro percutaneous absorption of arildone, a highly lipophilic drug, and the apparent no-effect of the penetration enhancer Azone in excised human skin.
Baker EJ; Hadgraft J
Pharm Res; 1995 Jul; 12(7):993-7. PubMed ID: 7494819
[TBL] [Abstract][Full Text] [Related]
34. Transdermal delivery of buprenorphine through cadaver skin.
Roy SD; Roos E; Sharma K
J Pharm Sci; 1994 Feb; 83(2):126-30. PubMed ID: 8169777
[TBL] [Abstract][Full Text] [Related]
35. Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of tenoxicam through hairless mouse skin.
Gwak HS; Chun IK
Int J Pharm; 2002 Apr; 236(1-2):57-64. PubMed ID: 11891070
[TBL] [Abstract][Full Text] [Related]
36. Development of ciclopirox olamine topical formulations: evaluation of drug release, penetration and cutaneous retention.
Pinheiro VA; Serikaku D; Baby AR; Velasco MV; Kaneko TM; Consiglieri VO
Pharm Dev Technol; 2015 Mar; 20(2):197-203. PubMed ID: 24286179
[TBL] [Abstract][Full Text] [Related]
37. Enhanced permeation of polar compounds through human epidermis. I. Permeability and membrane structural changes in the presence of short chain alcohols.
Goates CY; Knutson K
Biochim Biophys Acta; 1994 Oct; 1195(1):169-79. PubMed ID: 7918560
[TBL] [Abstract][Full Text] [Related]
38. Permeation characteristics of 8-methoxypsoralen through human skin; relevance to clinical treatment.
Anigbogu AN; Williams AC; Barry BW
J Pharm Pharmacol; 1996 Apr; 48(4):357-66. PubMed ID: 8794983
[TBL] [Abstract][Full Text] [Related]
39. Passive skin penetration enhancement and its quantification in vitro.
Moser K; Kriwet K; Naik A; Kalia YN; Guy RH
Eur J Pharm Biopharm; 2001 Sep; 52(2):103-12. PubMed ID: 11522474
[TBL] [Abstract][Full Text] [Related]
40. Supersaturation as a tool for skin penetration enhancement.
Cilurzo F; Casiraghi A; Selmin F; Minghetti P
Curr Pharm Des; 2015; 21(20):2733-44. PubMed ID: 25925122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
